{"id":18113,"date":"2012-01-09T00:00:45","date_gmt":"2012-01-09T05:00:45","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=18113"},"modified":"2012-01-09T00:24:11","modified_gmt":"2012-01-09T05:24:11","slug":"the-games-begin","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/01\/09\/the-games-begin\/","title":{"rendered":"the games begin&#8230;"},"content":{"rendered":"<blockquote>\n<div align=\"center\"><a target=\"_blank\" href=\"http:\/\/www.statesman.com\/news\/texas\/state-attorney-general-sued-drug-company-2089793.html?viewAsSinglePage=true\"><u><strong><font color=\"#200020\">State attorney general sued drug company<\/font><\/strong><\/u><\/a><br \/> <strong><font color=\"#200020\"><sup>Abbott: state paid excessively to Johnson &amp; Johnson for Risperdal<\/sup><\/font><\/strong><br \/> <strong><font color=\"#200020\">Austin Statesman<\/font><\/strong><br \/> By Tim Eaton<br \/> Jan.8, 2012<\/div>\n<p align=\"justify\"><sup>Texas Attorney General Greg Abbott is pitted against one of the  largest multinational pharmaceutical companies in a trial starting this  week that could bring the state more than $1 billion one of its largest  potential awards since a multibillion-dollar tobacco settlement in 1998. Abbott  is charging that Johnson &amp; Johnson Inc., its wholly owned  subsidiary Janssen Pharmaceutical LLC and five other related companies  defrauded the state in a &quot;sophisticated marketing scheme&quot; that caused  the Texas Medicaid Program to pay too much  for Janssen&#8217;s schizophrenia  drug Risperdal, the lawsuit says. The state also questions the  companies&#8217; marketing practices and alleges that the companies misled  state health officials about the drug&#8217;s effectiveness, the risk of side  effects and its suitability for pediatric use. The trial  is scheduled to begin 9 a.m. today  in Judge John Dietz&#8217;s 250th state District Court in Travis County&#8230;<\/sup><\/p>\n<p align=\"justify\"><sup>Texas got  involved with Risperdal litigation about six years ago, when Abbott&#8217;s  office joined a lawsuit filed by corporate whistle-blower Allen Jones,  who is a former employee of the office of the inspector general of  Pennsylvania. Jones has questioned the process for how Risperdal  was approved in Texas and how that information was used by other states  in their approval processes. Jones filed suit in 2004 after his  investigation in Pennsylvania led him to examine the companies&#8217; track  record in Texas. As a whistle-blower plaintiff, he alleged that the  companies overcharged the states and overstated the drug&#8217;s  effectiveness&#8230;<\/sup><\/p>\n<p align=\"justify\"><sup>The lawsuit says that  Johnson &amp; Johnson and its subsidiaries employed suspect tactics in  order to sell Risperdal in the public sector, which promised to be  especially lucrative. Eighty-five percent of Risperdal&#8217;s revenue was  projected to come from the public sector, because schizophrenic adults  tend to be poor and uninsured. &quot;Understanding the need to obtain  significant government buy-in to achieve their financial goals for  Risperdal, defendants set their sights on a state with one of the  largest Medicaid populations in the country &mdash; Texas,&quot; according to the  filing by the state and Jones. But getting a state like Texas to  put a drug on a list of preferred medications &mdash; which the companies  ultimately accomplished &mdash; can be a tremendous undertaking.<\/sup><\/p>\n<p align=\"justify\"><sup>The  lawsuit discusses the challenge for the companies to persuade  decision-makers in Texas&#8217; public medical agencies to make the move &mdash;  despite what it said was evidence that the drug is more expensive and no  more effective than older medications, the state and Jones say in their  lawsuit. Johnson &amp; Johnson and the related companies even  created a special business unit called the Public Health Systems and  Reimbursement Department  designed to push the drug in the public  sector, the lawsuit says. The companies also had to navigate the  Texas Medicaid Program&#8217;s cost-savings measures, and to do so the  companies employed a campaign that included misrepresentations about the  drug&#8217;s effectiveness and superiority over other drugs, the state  alleges.<\/sup><\/p>\n<div align=\"justify\"><sup>The state&#8217;s case outlines allegations of kickbacks &mdash;  &quot;money going directly to key decision-makers,&quot; the lawsuit says &mdash; paid  more than a decade ago to several doctors employed by the state&#8217;s Health  and Human Services Commission  to give Risperdal preference over other  antipsychotic drugs. Jones&#8217; lawsuit claims that Risperdal became  part of the treatment plan because of the drug companies&#8217; &quot;improper  influence&quot; over Dr.  Steven  Shon, the former medical director for  behavioral health at the Department of State Health Services. Shon had  served as a paid Janssen consultant and traveled the country promoting  the Texas plan&#8230; Jones&#8217;  legal team also charged that the company perfected its marketing skills  in Texas before reaching out to the other states in which it pushed for  expanded Risperdal prescriptions&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\"><img decoding=\"async\" hspace=\"4\" border=\"0\" align=\"right\" width=\"180\" src=\"http:\/\/1boringoldman.com\/images\/tmap-logo.gif\" \/>Nine hours and counting from now the TMAP\/J&amp;J suit finally makes it to a courtroom and the jury selection begins. I&#8217;ve only known about this case for a year. But for Allen Jones, it has been a decade since he first got the scent of the wrongdoing alleged in this case. The whistle-blower suit itself was filed eight years ago. I have no clue what it would be like to have something like this on my mind every day for a decade, much less what it would feel like to finally be going to court and testifying in a matter of days. Certainly, the financial stakes are high &#8211; the lawyers speak of a billion dollars. But there will be other high stake issues at play in this courtroom. This case brings up so many of the deceptive practices that characterized the invasion of the pharmaceutical industry into academic psychiatry and psychiatric practice, all put into action behind closed doors. With this case, there are added twists. J&amp;J targeted public mental health care. The taxpayers of the State of Texas were the victims along with the State&#8217;s mentally ill in hospitals, clinics, and prisons. TMAP was run by academic psychiatrists from Texas&#8217; medical schools<img loading=\"lazy\" decoding=\"async\" hspace=\"4\" height=\"132\" border=\"0\" align=\"left\" width=\"133\" src=\"http:\/\/1boringoldman.com\/images\/risperdal-7.gif\" \/>, and the psychiatrists who administered TMAP, traveling the country as TMAP evangelists to other States, were employed by the Texas Mental Health system. It&#8217;s hard to wrap my mind around the fact that the State&#8217;s own academic and institutional doctors were themselves agents of Johnson &amp; Johnson in defrauding the State&#8217;s taxpayers and the State&#8217;s mentally ill. Getting this story into the public eye is as important as any punitive damages that might come in this suit. Let the games begin&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>State attorney general sued drug company Abbott: state paid excessively to Johnson &amp; Johnson for Risperdal Austin Statesman By Tim Eaton Jan.8, 2012 Texas Attorney General Greg Abbott is pitted against one of the largest multinational pharmaceutical companies in a trial starting this week that could bring the state more than $1 billion one of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-18113","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=18113"}],"version-history":[{"count":5,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18113\/revisions"}],"predecessor-version":[{"id":18117,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/18113\/revisions\/18117"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=18113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=18113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=18113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}